They found that the mutation rate of TP53 is higher in chRCC with a frequency of 31.8%, while TP53 in ccRCC and pRCC has a much lower mutation rate at 3.24% and 2.48%, respectively. The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.